Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May;16(5):246-51.
doi: 10.3779/j.issn.1009-3419.2013.05.06.

[Pathological characteristic and clinical management of pulmonary carcinoid]

[Article in Chinese]
Affiliations

[Pathological characteristic and clinical management of pulmonary carcinoid]

[Article in Chinese]
Lei Zhu et al. Zhongguo Fei Ai Za Zhi. 2013 May.

Abstract

Background and objective: Treatment of pulmonary carcinoid is a comprehensive modality focusing on surgery. Thus, accurate and timely preoperative and intraoperative pathological diagnoses are very crucial. The aim of this study is to retrospectively analyze the pathological characteristics of pulmonary carcinoid, its natural history, and patterns of disease progression to obtain evidence for clinical decision making.

Methods: Clinical and pathological data of 32 patients with pulmonary carcinoid were retrieved and retrospectively analyzed. The pathological characteristics and their relationship with clinical diagnosis and treatment effect were systematically studied.

Results: Among the 32 patients, 18 had typical carcinoid and 14 had atypical carcinoid. The male-to-female ratio was 2.2:1, and the average age was (44±15) years. Almost half of the patients were discovered by accident. The average maximum diameter was (3.1±1.3) cm. About 27 of all 32 cases (84.4%) were stage I, 2 were stage IIa, 2 were stage IIIa, and 1 was stage IV. The follow-up time was 5.2-9.7 years. The 5-year progression free survival of 15 typical carcinoid patients and 12 atypical carcinoid patients were 100% and 92.9%, respectively. The characteristic neuroendocrine morphology and variable expression levels of cytokeratin, chromogranin A, synaptophysin, CD56, and index of Ki-67 were important factors that differentiated pulmonary carcinoid from other tumors.

Conclusions: Pathological diagnosis of pulmonary carcinoid must combine morphology with immunohistochemistry. Early-stage patients can also achieve good effect after surgery.

背景与目的 肺类癌采取以手术为主的多学科治疗,准确及时的病理诊断至关重要。本研究探讨肺类癌的病理特质,结合回顾性分析患者的转归预后,为临床决策提供依据。方法 收集支气管肺内发生的类癌手术标本32例,回顾性分析患者相关的临床病理资料,系统研究病灶病理学表现与临床诊断和治疗效果的相关性。结果 32例肺类癌患者中,典型类癌18例,不典型类癌14例;男女性别比为2.2:1;平均年龄(44±15)岁;近半数患者无症状;肿瘤最大径(3.1±1.3) cm;绝大多数为I期患者(84.4%, 27/32),余IIa期2例,IIIa期2例,IV期1例;随访时间为5.2年-9.7年;其中典型类癌随访15例,5年无进展生存率为100%;不典型类癌随访12例,5年无进展生存率为92.9%;肺类癌病理组织学的特质是典型的神经内分泌形态伴细胞角蛋白阳性,嗜铬素A、突触素和CD56等神经内分泌指标的表达,Ki-67指数的高低有助于鉴别诊断。结论 肺类癌的病理鉴别诊断应结合相关酶标染色,积极争取手术是适宜的临床决策。

PubMed Disclaimer

Figures

1
1
肺类癌的病理表现。A:肺典型和不典型类癌中最常见的器官样结构生长方式。肿瘤细胞较一致,胞浆中等量,嗜酸性,核呈细颗粒状(HE, ×40);B:肺非典型类癌可出现灶状坏死(HE, ×40);C:免疫组化显示类癌嗜铬素A阳性(×40);D:本例典型类癌Ki-67指数约为2%(×40);E:本例不典型类癌Ki-67指数约为10%(×40);F:本例类癌组织学形态类似硬化性血管瘤(HE, ×40)。 The pathological pattern of lung carcinoid. A: An organoid growth pattern is the most common histologic pattern in both typical and atypical carcinoid. Tumor cells have uniform cytologic features with a moderate amount of eosinophilic cytoplasm. Nuclear features usually consist of finely granular chromatin; B: The necrosis usually consists of small punctate foci in atypical carcinoid; C: Imunohistochemistry shows chromogranin A is positive in carcinoid; D: The Ki-67 index in carcinoid is lower; E: The Ki-67 index in atyical carcinoid is higher; F: The morphology in carcinoid is similar as sclerosing hemangioma.

References

    1. Chen LC, Travis WD, Krug LM. Pulmonary neuroendocrine tumors: what (little) do we know? J Natl Compr Canc Netw. 2006;4(6):623–630. doi: 10.6004/jnccn.2006.0051. - DOI - PubMed
    1. Yao JC, Hassan M, Phan A, et al. One hundred years after carcinoid: epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States. J Clin Oncol. 2008;26(18):3063–3072. doi: 10.1200/JCO.2007.15.4377. - DOI - PubMed
    1. Travis WD, Brambilla E, Müller-Hermelink HK, et al. Pathology and genetics of tumours of the lung, pleura, thymus and heart. In World Health Organization classification of tumours. IARC Press; 2004.

    1. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest. 2009;136(1):260–271. doi: 10.1378/chest.08-0978. - DOI - PubMed
    1. Travis WD, Rush W, Flieder DB, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol. 1998;22(8):934–944. doi: 10.1097/00000478-199808000-00003. - DOI - PubMed

Publication types